Assembly areaHeadingRich textFirst column contentFOREWORDBy Christa Wirthumer-HocheChair of EMA’s Management BoardRead moreSecond column contentINTRODUCTIONBy Guido RasiEMA Executive directorRead moreHeadingRich textCHAPTER 1KEY ACHIEVEMENTS IN 2019Evaluation and monitoring of medicines: highlightsCard imageImageRelocation to the Netherlands and preparations for BrexitCard imageImageNew EU legislation applicable to EMACard imageImageShortages and availability of medicinesCard imageImageRegulatory science strategy to 2025Card imageImageA decisive year for big data in medicines regulation: towards data-driven decision-makingCard imageImageNitrosamine impurities: the network's responseCard imageImageAntimicrobial resistanceCard imageImage2019 - year in brief Explore CHAPTER 2KEY FIGURES IN 2019Human medicinesCard imageImageVeterinary medicinesCard imageImageInspections and complianceCard imageImageNetwork, stakeholders, administration and communicationCard imageImageNextForeword
A decisive year for big data in medicines regulation: towards data-driven decision-makingCard imageImage
